SJS Investment Consulting
AMPH icon

SJS Investment Consulting’s Amphastar Pharmaceuticals AMPH Stock Holding History

SJS Investment Consulting’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.6K Buy
373
+367
+6,117% +$7.93K ﹤0.01% 1368
2026
Q2 		$122 Buy
+6
New +$121 ﹤0.01% 2571
2025
Q1 		– Sell
-1
Closed -$38 – 1604
2024
Q4 		$38 Hold
1
– – ﹤0.01% 1567
2024
Q3 		$49 Hold
1
– – ﹤0.01% 1618
2024
Q2 		$40 Sell
1
-1
-50% -$41 ﹤0.01% 1627
2024
Q1 		$88 Sell
2
-3
-60% -$155 ﹤0.01% 1582
2023
Q4 		$310 Buy
5
+1
+25% +$53 ﹤0.01% 1363
2023
Q3 		$184 Buy
4
+2
+100% +$109 ﹤0.01% 1469
2023
Q2 		$115 Buy
2
+1
+100% +$44 ﹤0.01% 1502
2023
Q1 		$38 Hold
1
– – ﹤0.01% 1537
2022
Q4 		$28 Hold
1
– – ﹤0.01% 1566
2022
Q3 		$0 Buy
+1
New +$33 ﹤0.01% 1021

Other funds holding AMPH

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LAM Group
LAM Group Lake Oswego, Oregon $199M AUM 14.21% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

SJS Investment Consulting's AMPH Position: Q3 2026 in Review

SJS Investment Consulting increased its Amphastar Pharmaceuticals (AMPH) stake by 6,117% in Q3 2026, buying an estimated $7.93K and bringing the position to 373 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

SJS Investment Consulting first reported a position in AMPH in Q3 2022 and has held it in 12 quarters since. 119 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • SJS Investment Consulting held 373 shares of Amphastar Pharmaceuticals worth $9.6K as of Q3 2026.
  • SJS Investment Consulting bought 367 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $7.93K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1368 holding.
  • SJS Investment Consulting first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • 119 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.